Alteration of CD4+CD25+Foxp3+ T cell level in Kawasaki disease

Korean Journal of Pediatrics

Volumn 54, Issue 4, 2011, Pages 157-162

  Sohn, Su Ye ^a   Song, Young Wooh ^a   Yeo, Yun Ku ^a   Kim, Kyung ^a   Jang, Gi Young ^a   Woo, Chan Wook ^a   Lee, Jung Hwa ^a   Lee, Kwang Chul ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Kawasaki disease; Regulatory T cell

Indexed keywords

EID: 79959848292     PISSN: 17381061     EISSN: 20927258     Source Type: Journal    
DOI: 10.3345/kjp.2011.54.4.157     Document Type: Article

References (26)

1. Park YW. Epidemiology of Kawasaki disease in Korea. Korean J Pediatr 2008;51:452-6.
2. +T cells inpatients with systemic lupus erythematosus. J Immunol 2009;182:1689-95.
3. highregulatory cells in human peripheral blood. J Immunol 2001;167:1245-53.
4. Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis 2001;184:940-3.
5. +T-regulatory cells in both nonatopic and atopic individuals. J Allergy Clin Immunol 2007;120:429-36.
6. +) regulatory T cells in patients with systemic lupus erythematosus Lupus 2007;16:489-96.
7. +regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology 2008;127:196-205.
8. Sonobe T, Kiyosawa N, Tsuchiya K, Aso S, Imada Y, Imai Y, et al. Prevalence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int 2007;49:421-6.
9. Tsuchiya K, Imada Y, Aso S, Sonobe T. Diagnosis of incomplete Kawasaki disease. Nippon Rinsho 2008;66:321-5.
10. Ministry of Health and Welfare. Report of subcommitte on standardization of diagnostic criteria and reporting of coronary artery in Kawasaki disease. Tokyo, Japan: Ministry of Health and Welfare; 1984.
11. +T regulatory cells. J Immunol Methods 2007;324:92-104.
12. Franco A, Shimizu C, Tremoulet AH, Burns JC. Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease. Autoimmunity 2010;43:317-24.
13. Workman CJ, Szymczak-Workman AL, Collison LW, Pillai MR, Vignali DAA. The development and function of regulatory T cells. Cell Mol Life Sci 2009;66:2603-22.
14. +cells in systemic lupus erythematosus. Arthritis Res Ther 2010;12:101.
15. +T cells in patients with systemic lupus erythematosus: a novel hypothesis. Open Rheumatol J 2009;3:22-4.
16. Park JK. Immunopathogenesis of Kawasaki disease. J Korean Pediatr Heart 2006;10:349-53.
17. Tha-In T, Bayry J, Metselaar HJ, Kaveri SV, Kwekkeboom J. Modulation of the cellular immune system by intravenous immunoglobulin. Trends Immunol 2008;29:608-15.
18. Maddur MS, Othy S, Hegde P, Vani J, Lacroix-Desmazes S, Bayry J, et al. Immunomodulation by intravenous immunoglobulin: role of regulatory T cells. J Clin Immunol 2010;30:4-8.
19. Kessel A, Ammuri H, Peri R, Pavlotzky ER, Blank M, Shoenfeld Y, et al. Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function. J Immunol 2007;179:5571-5.
20. +CD25hi T-regulatory cells. Blood 2006;108:253-61.
21. high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheum Dis 2006;65:1512-7.
22. Wing K, Sakaguchi S. Regulatory T cells as potential immunotherapy in allergy. Curr Opin Allergy Clin Immunol 2006;6:482-8.
23. Fink LN. Induction of regulatory T cells by probiotics: potential for treatment of allergy? Clin Exp Allergy 2010;40:5-8.
24. Furukawa S, Matsubara T, Motohashi T, Tsuda M, Sugimoto H, Yabuta K. Immunological abnormalities in Kawasaki disease with coronary artery lesions. Acta Paediatr Jpn 1991;33:745-51.
25. Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol 1990;56:29-36.
26. Nonoyama S. Immunological abnormalities and endothelial cell injury in Kawasaki disease. Acta Paediatr Jpn 1991;33:752-5.